Risk Factors for Recurrence after Resection of Hepatitis C Virus-related Hepatocellular Carcinoma

被引:0
|
作者
Shoji Kubo
Kazuhiro Hirohashi
Hiromu Tanaka
Tadashi Tsukamoto
Taichi Shuto
Takashi Ikebe
Takatsugu Yamamoto
Kenichi Wakasa
Shuhei Nishiguchi
Tetsuo Kuroki
Hiroaki Kinoshita
机构
[1] Second Department of Surgery,
[2] Osaka City University Medical School,undefined
[3] 1-4-3 Asahimachi,undefined
[4] Abeno-ku,undefined
[5] Osaka 545-8585,undefined
[6] Japan,undefined
[7] Second Department of Pathology,undefined
[8] Osaka City University Medical School,undefined
[9] 1-4-3 Asahimachi,undefined
[10] Abeno-ku,undefined
[11] Osaka 545-8585,undefined
[12] Japan,undefined
[13] Department of Pathology,undefined
[14] Osaka City University Hospital,undefined
[15] 1-5-3 Asahimachi,undefined
[16] Abeno-ku,undefined
[17] Osaka 545-8586,undefined
[18] Japan,undefined
[19] Third Department of Internal Medicine,undefined
[20] Osaka City University Medical School,undefined
[21] 1-4-3 Asahimachi,undefined
[22] Abeno-ku,undefined
[23] Osaka 545-8585,undefined
[24] Japan,undefined
来源
World Journal of Surgery | 2000年 / 24卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although there have been many studies of the risk factors for recurrence after resection of hepatocellular carcinoma (HCC), the subjects were patients with various viral status in the previous studies, and hepatitis C viremia has not been evaluated. We investigated risk factors, including hepatic C viremia and histologic findings of noncancerous hepatic tissue, for recurrence after resection of hepatitis C virus (HCV)-related HCC. A total of 223 patients who underwent liver resection for HCV-related HCC were studied. HCV viremia, laboratory data, degree of HCC malignancy, histologic findings in noncancerous hepatic tissue, preoperative interferon therapy, and operative methods were evaluated for recurrence risk by univariate and multivariate analyses. Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin, and the proportion of patients with a high histologic activity score (mild to severe active hepatitis) were significantly higher in patients with HCV viremia than in those without viremia. Serum albumin was significantly lower in patients with HCV viremia. By univariate analysis, older age (> 65 years old), HCV viremia, elevated AST (> 40 IU/L) and ALT (> 45 IU/L), large tumors (> 40 mm), multiple HCCs, moderately or poorly differentiated HCC, portal invasion, mild to severe active hepatitis, and lack of preoperative interferon therapy were risk factors for recurrence. Multivariate analysis showed that older age, HCV viremia, high AST, multiple HCCs, and portal invasion were independent risk factors. For HCV-related HCCs, not only the degree of maliganacy of the HCC but also HCV viremia and active hepatitis are risk factors for recurrence.
引用
收藏
页码:1559 / 1565
页数:6
相关论文
共 50 条
  • [31] Secondary prevention of hepatitis C virus-related hepatocellular carcinoma
    Lin, SM
    Chu, CM
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (10) : 1475 - 1477
  • [32] Letter to the Editor: Re: Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
    Kim, Beom Kyung
    Kim, Seung Up
    HEPATOLOGY, 2021, 73 (01) : 466 - 466
  • [33] Molecular markers of hepatitis C virus-related hepatocellular carcinoma
    Sultan, Ahmed S.
    El Gendy, S.
    Hessien, Mohamed
    El Sherbiny, Mahmoud
    Ibrahim, Abdel Selam M.
    Sherif, Zaki A.
    CANCER BIOLOGY & THERAPY, 2006, 5 (06) : 623 - 629
  • [34] Reply to: Correspondence on "Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection"
    Choi, Jonggi
    JOURNAL OF HEPATOLOGY, 2022, 77 (05) : 1472 - 1474
  • [35] Surgical approach for hepatitis C virus-related hepatocellular carcinoma
    Shindoh, Junichi
    Hashimoto, Masaji
    Watanabe, Goro
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (01) : 70 - 77
  • [36] Antiviral Therapy Decreases Recurrence of Hepatitis B Virus-related Hepatocellular Carcinoma after Curative Resection: A Meta-analysis
    Zhou, Yanming
    Zhang, Zhansai
    Zhao, Yanfang
    Wu, Lupeng
    Li, Bin
    WORLD JOURNAL OF SURGERY, 2014, 38 (09) : 2395 - 2402
  • [37] Letter to the Editor: Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
    Yuan, Guandou
    Yao, Jianni
    Yu, Jingjing
    Xie, Xuemei
    He, Songqing
    HEPATOLOGY, 2021, 73 (03) : 1240 - 1240
  • [38] Predictors of Recurrence in Hepatitis C Virus Related Hepatocellular Carcinoma after Hepatic Resection: A Retrospective Cohort Study
    Wahab, Mohamed Abdel
    Shehta, Ahmed
    Hamed, Hosam
    El Nakeeb, Ayman
    Salah, Tarek
    EURASIAN JOURNAL OF MEDICINE, 2014, 46 (01): : 36 - 41
  • [39] Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
    Hiroaki Hagihara
    Kazuhiro Nouso
    Yoshiyuki Kobayashi
    Yoshiaki Iwasaki
    Shinichiro Nakamura
    Kenji Kuwaki
    Junichi Toshimori
    Hirokazu Miyatake
    Hideki Ohnishi
    Hidenori Shiraha
    Kazuhide Yamamoto
    International Journal of Clinical Oncology, 2011, 16 : 210 - 220
  • [40] Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
    Hagihara, Hiroaki
    Nouso, Kazuhiro
    Kobayashi, Yoshiyuki
    Iwasaki, Yoshiaki
    Nakamura, Shinichiro
    Kuwaki, Kenji
    Toshimori, Junichi
    Miyatake, Hirokazu
    Ohnishi, Hideki
    Shiraha, Hidenori
    Yamamoto, Kazuhide
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (03) : 210 - 220